Lp-PLA2 and Coronary Atherosclerosis in Humans

NACompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Coronary AtherosclerosisEndothelial Dysfunction
Interventions
OTHER

Blood sampling from the Coronary Sinus and Aorta

Blood samples will be obtained from the aorta and the coronary sinus during the clinically scheduled angiogram and endothelial function testing.

PROCEDURE

Intravascular Ultrasound of the coronary artery.

Intravascular Ultrasound will be completed for those subjects testing positive for coronary endothelial dysfunction during a clinically scheduled angiogram and endothelial function testing.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Aging (NIA)

NIH

lead

Mayo Clinic

OTHER

NCT01557088 - Lp-PLA2 and Coronary Atherosclerosis in Humans | Biotech Hunter | Biotech Hunter